This activity is designed to equip clinicians with knowledge and skills to apply evidence-based, guideline-informed approaches to the diagnosis and management of eosinophilic esophagitis (EoE). Participants will gain proficiency in the diagnostic process, which integrates symptom assessment, esophageal biopsy, and evaluation of comorbid atopic conditions to support prompt and accurate diagnosis. The program explores current guideline-directed management strategies, including the role of targeted biologic therapies against type 2 inflammation in suitable patients, with emphasis placed on critically evaluating the benefit–risk profiles of these therapies to inform individualized treatment decisions. Finally, learners will gain expertise in creating personalized, shared decision–making–driven treatment plans that incorporate patient preferences and evidence-based monitoring protocols to achieve sustained remission and prevent long-term complications.

RELEASED DATE: February 05, 2026
EXPIRATION DATE: February 05, 2027

This RESTORE gamification enduring activity will focus on the epidemiology, pathophysiology, diagnosis, and management of pediatric eosinophilic esophagitis (EoE). The program is designed to support healthcare professionals involved in the care of children and adolescents with EoE, with an emphasis on age-specific disease presentation, diagnostic considerations, and treatment strategies. Participants will enhance their ability to accurately diagnose pediatric EoE and to individualize therapy based on current clinical guidelines, emerging evidence, growth and developmental considerations, family preferences, and patient-specific characteristics.

RELEASED DATE: February 05, 2026
EXPIRATION DATE: February 05, 2027